Brevel

Brevel is an Israeli food-tech startup built around illuminated fermentation, a process that combines controlled light exposure with fermentation to grow microalgae ingredients in indoor bioreactors. The company’s public product line centers on a neutral-tasting protein ingredient and a companion biomass ingredient, both designed to fit into food, beverage, nutrition, and adjacent formulation workflows without the color, flavor, or supply inconsistency issues that often limit algae-based inputs. That positioning matters because it moves Brevel out of the “novel ingredient demo” bucket and into a more practical industrial-ingredient category where functionality, labeling, and batch consistency drive purchase decisions.

The technical thesis is straightforward but ambitious: use microalgae as a high-functionality input while solving the two hard problems that usually keep alternative proteins from scaling—cost and sensory performance. Brevel’s product pages emphasize neutral taste, high solubility, amino-acid completeness, and repeatable production, while also highlighting certifications and formulation flexibility for supplements, food and beverage systems, and alternative-protein blends. In other words, the company is not just selling algae as a sustainability story; it is trying to make algae behave like a reliable ingredient platform that manufacturers can actually use at scale.

Brevel’s public operating history suggests a company that has progressed beyond pure lab concept work. Its about page says the company was founded in 2017 by the three Golan brothers, and public profiles place the headquarters in Rehovot, Israel with a team in the roughly 40-50 employee range. In 2024 the company opened a commercial plant in Israel, and in 2025 public reporting described an expanded seed round reaching $25 million. Those are meaningful signals because they indicate the business is already spending against manufacturing, process scale-up, and customer qualification rather than only producing investor narratives. For a food-security company, the existence of a real plant is often the difference between a nice thesis and a usable supply chain asset.

From a market perspective, Brevel sits in the intersection of alternative protein, specialty ingredients, and industrial biotech. The company’s relevance to strategic food security is not abstract: countries and large food manufacturers increasingly care about ingredient resilience, water use, land use, climate exposure, and supply continuity. Microalgae ingredients are attractive because they can be produced in controlled environments with less dependence on seasonal agriculture, arable land, and the specific climate conditions that constrain crop and livestock systems. That makes Brevel more than a consumer wellness brand; it is a materials-and-supply-chain play for a world where protein and functional ingredients are becoming infrastructure questions.

The dual-use angle is real but indirect. Brevel is not a defense company and does not market weapons-adjacent products, yet its core capability—stable, indoor, year-round production of high-value protein ingredients—does have strategic resilience value in food-security, humanitarian, and emergency-preparedness contexts. A society with better domestic or allied ingredient production is less exposed to shipping disruption, commodity shocks, conflict-related logistics failures, or agricultural climate volatility. That is why Brevel fits a Claw & Talon thesis that includes resilience, critical supply chains, and dual-use enabling technologies even when the customer set is primarily commercial.

The competitive landscape is crowded and the diligence questions are practical rather than speculative. Brevel competes against other algae, fermentation, and alternative-protein ingredient companies, plus incumbents in plant-protein sourcing that can often win on scale, distribution, or procurement relationships. Its possible edge is the combination of process novelty, neutral sensory profile, and a manufacturing story that appears closer to industrialization than many earlier-stage food-tech peers. The key questions are whether the company can keep cost curves moving down, hold contamination and consistency under control, win customer specs, and convert a strong strategic narrative into repeatable commercial demand. If those pieces hold, Brevel can become a durable ingredient platform; if not, it risks remaining a technically interesting but capital-intensive niche.